ArticlePLoS pathogens2025
Two receptor-targeting mechanisms of lambda-like siphophage Gifsy-1 of Salmonella Typhimurium.
Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Antibiofilm efficacy of phage W5 against antimicrobial-resistantApplied and environmental microbiology · 2026Article
- Systematic evaluation of phage cocktail-ciprofloxacin combination therapy against multidrug-resistantMicrobiology spectrum · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
The receptor-targeting mechanisms by which λ-like siphophages establish infection in gram-negative bacteria remain poorly characterized. This study demonstrated that the λ-like phage Gifsy-1, which exhibits broad lytic activity in Salmonella enterica, employs two receptor-targeting mechanisms mediated by the side tail fiber Stf and central tail tip J dependent on O-polysaccharide (OPS) production. In rough (OPS-deficient LPS) Salmonella Typhimurium strains, Gifsy-1 employs multiple receptor-targeting: the J protein binds OmpC, OmpX, and BtuB, while the Stf protein targets galactose II (Gal II) of the lipopolysaccharide (LPS) core oligosaccharide. OmpC uniquely serves dual roles as the primary receptor (mediating initial adsorption) and secondary receptor (facilitating DNA ejection), whereas the other three receptors function exclusively as primary receptors to prompt high-efficiency phage adsorption. In contrast, the surface OPS in smooth Salmonella Typhimurium blocks J protein interactions with membrane proteins. Instead, Gifsy-1 utilizes core oligosaccharide Gal II, located between the OPS layer and outer membrane, as its necessary receptor for both adsorption and DNA ejection. This study intriguingly identified a shift in the receptor role of the core oligosaccharide in Gifsy-1 infection, which confers Gifsy-1 adaptation to OPS switching. The adaptability of the two targeting-mechanisms contributes to the understanding of the biological functions of Gifsy-1 and provides a blueprint for engineering phage therapy against multidrug-resistant Salmonella enterica.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.